Daniel Weckbecker
Wendelsheim, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's disease.
Journal: Acta neuropathologica
Published: October 23, 2024
[11C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 09, 2020
11 C Radiolabeling of anle253b: a Putative PET Tracer for Parkinson's Disease That Binds to α-Synuclein Fibrils in vitro and Crosses the Blood-Brain Barrier.
Journal: ChemMedChem
Published: December 12, 2019
Potential sources of interference with the highly sensitive detection and quantification of alpha-synuclein seeds by qRT-QuIC.
Journal: FEBS open bio
Published: November 06, 2019
Tau-induced mitochondrial membrane perturbation is dependent upon cardiolipin.
Journal: Biochimica et biophysica acta. Biomembranes
Published: June 07, 2019
Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: May 24, 2018
Photophysics of diphenyl-pyrazole compounds in solutions and α-synuclein aggregates.
Journal: Biochimica et biophysica acta. General subjects
Published: August 23, 2017
Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies.
Journal: Acta neuropathologica
Published: July 24, 2015
Methods to study the biogenesis of membrane proteins in yeast mitochondria.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 03, 2013
Biogenesis of mitochondrial proteins.
Journal: Advances in experimental medicine and biology
Published: June 26, 2012
Last Updated: 09/26/2026